311 related articles for article (PubMed ID: 28502960)
1. Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting.
Kuwana M
J Nippon Med Sch; 2017; 84(2):56-63. PubMed ID: 28502960
[TBL] [Abstract][Full Text] [Related]
2. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
4. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
5. Late onset systemic sclerosis with seronegativity: a rare presentation of an uncommon disease.
Saxena D; Jain D; Yadav M; Giri K; Yadav T; Jain P
Reumatismo; 2019 Oct; 71(3):166-170. PubMed ID: 31649382
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic criteria of systemic sclerosis.
Hudson M; Fritzler MJ
J Autoimmun; 2014; 48-49():38-41. PubMed ID: 24461384
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
9. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
[TBL] [Abstract][Full Text] [Related]
10. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
[TBL] [Abstract][Full Text] [Related]
11. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
[TBL] [Abstract][Full Text] [Related]
12. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.
Cavazzana I; Ceribelli A; Airo' P; Zingarelli S; Tincani A; Franceschini F
Autoimmun Rev; 2009 Jun; 8(7):580-4. PubMed ID: 19393210
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
[TBL] [Abstract][Full Text] [Related]
14. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
Mierau R; Genth E
Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
[TBL] [Abstract][Full Text] [Related]
15. [Nuclear auto-antibodies: a useful tool for the diagnosis, the classification and the prognosis of systemic sclerosis].
Hachulla E; Dubucquoi S
Rev Med Interne; 2004 Jun; 25(6):442-7. PubMed ID: 15158315
[TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibody in systemic sclerosis (scleroderma).
Okano Y
Rheum Dis Clin North Am; 1996 Nov; 22(4):709-35. PubMed ID: 8923592
[TBL] [Abstract][Full Text] [Related]
17. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
18. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
19. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
Satoh T; Ishikawa O; Ihn H; Endo H; Kawaguchi Y; Sasaki T; Goto D; Takahashi K; Takahashi H; Misaki Y; Mimori T; Muro Y; Yazawa N; Sato S; Takehara K; Kuwana M
Rheumatology (Oxford); 2009 Dec; 48(12):1570-4. PubMed ID: 19808694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
